27.02.2019 | Correction
Correction to: Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review
Erschienen in: Clinical Rheumatology | Ausgabe 6/2019
Einloggen, um Zugang zu erhaltenExcerpt
Correction to: Clinical Rheumatology
Author [ref]
|
Study design
|
Outcome and target
|
Provider sample
|
RA patients (n)
|
Intervention
|
Comparison group
|
Post-evaluation
|
Interventions targeting providers
|
|||||||
Ledwich et al. [21]
|
Pre-post quasi experimental intervention design
|
Vaccination rates (patient) and Documentation of prescription (provider)
|
Health care providers; physician, fellow, resident, or nurse practitioner (n not reported)
|
758
|
Electronic Health record (EHR) best practice alert (BPA)
|
None
|
Did not report
|
Desai et al. [22]
|
Cluster, Controlled trial; Quality improvement intervention strategy
|
Vaccination rates (number of patients up to date) (patient)
|
Rheumatologists (n = 14)
|
3717
|
Point-of-care paper reminder forms
|
21 Rheumatologists
|
Assessed monthly (for a median of 16 months)
|
Interventions targeting providers and patients
|
|||||||
Baker et al. [23]
|
Quasi-experimental: Pre-post system-level intervention for quality improvement
|
Vaccination rates (patient)
|
Rheumatologists and primary care physician (n = 8)
|
1255
|
Reminders to prescribe vaccination, performance feedback to physicians and letters to patients
|
None
|
Assessed monthly for 12 months
|
Sheth et al. [24]
|
Pre-post quasi-experimental quality improvement intervention design
|
Vaccination rates (patient) and documentation rate (provider)
|
Physicians and staff (n not reported)
|
1554
|
Real-time electronic medical record (EMR) based alert system (BPA), coupled with patients and staff education and physician feedback and interval assessment
|
None
|
Did not report
|
Broderick et al. [25]
|
Quasi-experimental, Pre-post multimodal intervention
|
Decrease frequency of any missed opportunities for vaccination and vaccine attitude (0–100) (provider)
|
Rheumatologists (n not reported)
|
197
|
Multimodal intervention using education session, EMR-based alerts and personalised e-mail reminders for patient
|
None
|
Assessed each 3 months for 12 months
|
Author [ref]
|
Pre-intervention measures (HCPs)
|
Post-intervention measures (HCPs)
|
Pre-intervention measures (patients)
|
Post- intervention measures (patients)
|
|||
Interventions targeting providers
|
|||||||
Ledwich et al. [21]
|
NA
|
NA
|
Influenza vaccination rates: 47%; Influenza documentation: 47%; Pneumococcal vaccination rates: 19%; Pneumococcal documentation: 19%
|
Influenza vaccination rates: 65%; Influenza documentation: 67%; Pneumococcal vaccination rates: 41%; Pneumococcal documentation: 45%
|
|||
Desai et al. [22]
|
NA
|
NA
|
Intervention group rates of patients who were up-to-date for pneumococcal: 67.6%; Control group rate: 52.3%
|
Intervention group rates of patients who were up-to-date for pneumococcal: 80% (p < 0.006); Control group rate: 52.0% / (pre-post: p = 0.941)
|
|||
Interventions targeting providers and patients
|
|||||||
Baker et al. [23]
|
Not reported
|
Action ratea: first 2 months = 45–57%; months 3 to 5 = low of 38%; months 6–12 = 42–58%
|
Influenza: Ever received (90.2%); in previous season (79.4%); Pneumococcal: Ever received (28.7%); Herpes Zoster: Ever received (2.5%)
|
Influenza: Ever received (86.1%), in previous season (78.2%); Pneumococcal: Ever received (45.8%); Herpes Zoster: Ever received (4.5%)
|
|||
Sheth et al. [24]
|
Not reported
|
“Among 1002 patients for whom the BPA appeared, 581 (58%) resulted in either a vaccination (252; 43% vaccinated, 21; 4% vaccine prescribed) or documentation of reasons the vaccine was not prescribed (308; 53%)”
|
Herpes Zoster vaccination rates: 10.1%; vaccines documentation rates: 28%
|
Herpes Zoster vaccination rates: 51.7% (p < 0.0001).; vaccines documentation rates: 72.9% (p < 0.0001).
|
|||
Broderick et al. [25]
|
NA
|
NA
|
Frequency of any missed influenza vaccination: 47%; vaccination attitude: 50 ± 9
|
Frequency of any missed influenza vaccination: 23% (p < 0.001); vaccination attitude: 51 ± 9
|